Gettting started with Vardenafil (Levitra™️)

Levitra > vardenafil levitra


The degree of QT prolongation associated with

Indexing Status

Ozanimod has not been studied in patients taking concurrent QT prolonging drugs; however, QT prolonging drugs have been associated with TdP in patients with bradycardia. Pacritinib: (Major) Concomitant use of pacritinib and vardenafil increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Paliperidone: (Major) Concomitant use of vardenafil and paliperodone increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Panobinostat: (Major) QT prolongation has been reported with panobinostat therapy in patients with multiple myeloma in a clinical trial; use of panobinostat with other agents that prolong the QT interval is not recommended. Obtain an electrocardiogram at baseline and periodically during treatment.

Serious Side Effects

Hold panobinostat if the QTcF increases to >= 480 milliseconds during therapy; permanently discontinue if QT prolongation does not resolve. Drugs with a possible risk for QT prolongation and torsade de pointes that should be used cautiously and with close monitoring with panobinostat include vardenafil. Pasireotide: (Moderate) Concomitant use of vardenafil and pasireotide may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Pazopanib: (Major) Concomitant use of vardenafil and pazopanib increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Pentamidine: (Major) Concomitant use of vardenafil and pentamidine increases the risk of QT/QTc prolongation and torsade de pointes (TdP). sertraline is not clinically significant when administered within

Product Dosage Quantity + Bonus Price
Levitra Professional20mg360 + 6 Pills914.63€ 871.08€
Levitra Soft Tabs20mg30 + 2 Pills99.17€ 94.45€
Levitra Generic20mg90 + 8 Pills180.78€ 172.17€
Levitra Generic20mg30 + 4 Pills70.59€ 67.23€
Levitra Generic10mg360 + 10 Pills407.94€ 388.51€
Levitra Generic40mg270 + 10 Pills561.89€ 535.13€
Levitra Soft Tabs20mg120 + 8 Pills288.52€ 274.78€
Levitra Original20mg34 + 2 Pills188.51€ 179.53€
Levitra Generic60mg20 Pills81.30€ 77.43€
Levitra Generic40mg20 Pills67.56€ 64.34€
Levitra Generic10mg120 + 10 Pills178.59€ 170.09€
Levitra Generic10mg180 + 10 Pills246.74€ 234.99€
Levitra Original20mg14 + 2 Pills102.27€ 97.40€

the recommended dosage range; QT prolongation has been

Cited by (73)

PDE5 inhibitors, including vardenafil, may potentiate the hypotensive effects of riociguat. Risperidone: (Moderate) Concomitant use of vardenafil and risperidone may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Ritlecitinib: (Major) Do not use vardenafil orally disintegrating tablets with ritlecitinib due to increased vardenafil exposure; do not exceed a single dose of 5 mg per 24-hour period of vardenafil oral tablets. Vardenafil is primarily metabolized by CYP3A; ritlecitinib is a moderate CYP3A inhibitor. Ritonavir: (Major) Do not use vardenafil orally disintegrating tablets with ritonavir due to increased vardenafil exposure; do not exceed a single dose of 2.5 mg per 72-hour period of vardenafil oral tablets.

How is vardenafil supplied (dosage forms)?

Romidepsin: (Moderate) Concomitant use of vardenafil and romidepsin may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Sapropterin: (Moderate) Sapropterin acts as a cofactor in the synthesis of nitric oxide and may cause vasorelaxation. Caution should be exercised when administering sapropterin in combination with drugs that affect nitric oxide-mediated vasorelaxation such as phosphodiesterase inhibitors. When given together these agents may produce an additive reduction in blood pressure. The combination of sapropterin and a phosphodiesterase (PDE5) inhibitor did not significantly reduce blood pressure when administered concomitantly in animal studies. described at 2 times the maximum recommended dose.

What are the differences between vardenafil and tadalafil?

Ribociclib: (Major) Concurrent use of vardenafil orally disintegrating tablets with ribociclib should be avoided due to increased vardenafil exposure. If use of vardenafil oral tablets and ribociclib is required, do not exceed a single dose of 2.5 mg per 24-hour period of vardenafil oral tablets. Also, coadministration of ribociclib with vardenafil should be avoided if possible due to an increased risk for QT prolongation. Ribociclib has been shown to prolong the QT interval in a concentration-dependent manner. Vardenafil can produce QT prolongation at both therapeutic and supratherapeutic doses.

Possible Side Effects of Vardenafil

Ribociclib; Letrozole: (Major) Concurrent use of vardenafil orally disintegrating tablets with ribociclib should be avoided due to increased vardenafil exposure. Rilpivirine: (Moderate) Concomitant use of vardenafil and rilpivirine may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Riociguat: (Contraindicated) Use of riociguat and vardenafil is contraindicated due to the risk of hypotension. Discontinue riociguat at least 24 hours prior to vardenafil administration. Monitor for signs and symptoms of hypotension during transition of therapy. Silodosin: (Moderate) Due to the potential

  • Levitra is manufactured by Bayer Pharmaceuticals.
  • It is available in both tablet and generic forms.
  • The drug can be prescribed for men aged 18 and above.
  • Levitra's active ingredient is vardenafil hydrochloride.
  • It helps achieve erections suitable for sexual activity.
  • Taking fatty meals may delay the drug's onset.
  • Levitra does not protect against sexually transmitted diseases.
  • Use with caution if you have heart conditions.
  • It is essential to inform your doctor of all medications.
  • Vardenafil does not cure ED; it manages symptoms.

for symptomatic hypotension, patients should be

  • Vardenafil Levitra is a prescription medication for erectile dysfunction.
  • It works by increasing blood flow to the penis.
  • Vardenafil is marketed under the brand name Levitra.
  • It typically takes about 25-60 minutes to work.
  • The effects of vardenafil last up to 4-5 hours.
  • It should be taken on an empty stomach for faster results.
  • Common side effects include headache and flushing.
  • Vardenafil is contraindicated with nitrates.
  • Do not consume alcohol with vardenafil.
  • Always follow your doctor's dosage instructions.

stable on silodosin therapy before initiating

Medication Active Ingredient Onset of Action Duration Typical Dose Cost
Vardenafil (Levitra) Vardenafil 25-60 min Up to 5 hours 10 mg Moderate
Sildenafil (Viagra) Sildenafil 30-60 min 4-6 hours 50 mg Moderate
Tadalafil (Cialis) Tadalafil 30-60 min Up to 36 hours 10-20 mg Higher

therapy with the lowest dose of vardenafil.

CRD summary

Promethazine: (Moderate) Concomitant use of promethazine and vardenafil may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Promethazine; Dextromethorphan: (Moderate) Concomitant use of promethazine and vardenafil may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Promethazine; Phenylephrine: (Moderate) Concomitant use of promethazine and vardenafil may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Quetiapine: (Major) Concomitant use of vardenafil and quetiapine increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Quinidine: (Major) levitra alternative Vardenafil should be avoided in patients taking Class IA antiarrhythmics (disopyramide, procainamide, and quinidine).

Achieving treatment optimization with sildenafil citrate (Viagra(R)) in patients with erectile dysfunction

Quinine: (Major) Concomitant use of vardenafil and quinine increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Quizartinib: (Major) Concomitant use of quizartinib and vardenafil increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Ranolazine: (Major) Concomitant use of vardenafil and ranolazine increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Relugolix: (Moderate) Concomitant use of vardenafil and androgen deprivation therapy (i.e., relugolix) may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Relugolix; Estradiol; Norethindrone acetate: (Moderate) Concomitant use of vardenafil and androgen deprivation therapy (i.e., relugolix) may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Conversely, patients already receiving an optimized dose

Study design

Perphenazine: (Minor) Use vardenafil with caution in combination with perphenazine due to increased risk of QT prolongation. Perphenazine is associated with a possible risk for QT prolongation. Perphenazine; Amitriptyline: (Minor) Use vardenafil with caution in combination with perphenazine due to increased risk of QT prolongation. Phenoxybenzamine: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on alpha-blocker therapy before initiating therapy with the lowest dose of vardenafil. Phentolamine: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on alpha-blocker therapy before initiating therapy with the lowest dose of vardenafil.

What should I know about vardenafil before taking it?

Phenylephrine: (Minor) The therapeutic effect of phenylephrine injection may be decreased in patients receiving phosphodiesterase inhibitors. Pimavanserin: (Major) Concomitant use of vardenafil and pimavanserin increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Pimozide: (Contraindicated) Avoid concomitant use of vardenafil and pimozide due to an increased risk for torsade de pointes (TdP) and QT/QTc prolongation. Pitolisant: (Major) Concomitant use of vardenafil and pitolisant increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Ponesimod: (Major) In general, do not initiate ponesimod in patients taking vardenafil due to the risk of additive bradycardia, QT prolongation, and torsade de pointes (TdP). of vardenafil should be started on the lowest

Drug Interactions

Ponesimod initiation may result in a transient decrease in heart rate and atrioventricular conduction delays. Ponesimod has not been studied in patients taking concurrent QT prolonging drugs; however, QT prolonging drugs have been associated with TdP in patients with bradycardia. Posaconazole: (Contraindicated) The concurrent use of posaconazole with drugs that are associated with QT prolongation and are also CYP3A4 substrates, such as vardenafil, is contraindicated. Posaconazole is associated with QT prolongation, and vardenafil may cause QT prolongation at both therapeutic and supratherapeutic doses. Elevated plasma concentrations of vardenafil may also increase the risk for other vardenafil-related adverse events, such as prolonged erection or potential for syncope.

Study designs of evaluations included in the review

Prazosin: (Moderate) Due to the potential for symptomatic hypotension, patients should be stable on alpha-blocker therapy before initiating therapy with the lowest dose of vardenafil. Primaquine: (Moderate) Concomitant use of vardenafil and primaquine may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients. Procainamide: (Major) Vardenafil should be avoided in patients taking Class IA antiarrhythmics (disopyramide, procainamide, and quinidine). Prochlorperazine: (Minor) Use vardenafil with caution in combination with prochlorperazine due to increased risk of QT prolongation. Prochlorperazine is also associated with a possible risk for QT prolongation. dose of silodosin; increases in the alpha-blocker

  • Vardenafil requires a prescription; self-medicating is unsafe.
  • Take Levitra approximately 60 minutes before intimacy.
  • Do not take more than one dose per 24 hours.
  • Symptoms like priapism need immediate medical attention.
  • Levitra may cause nasal congestion or upset stomach.
  • Combining vardenafil with other ED drugs increases risks.
  • Alcohol can hinder the effectiveness of Levitra.
  • Levitra is designed for occasional use, not daily.
  • Precautions include monitoring for vision changes.
  • Seek medical advice if you experience allergic reactions.

dose should be done in a stepwise fashion.

Methods of synthesis

The additive effect of these agents has not been studied in humans. Saquinavir: (Contraindicated) Coadministration of saquinavir boosted with ritonavir is contraindicated with other drugs that may prolong the QT interval and which are primary CYP3A4 substrates, such as vardenafil. Saquinavir boosted with ritonavir is a strong CYP3A4 inhibitor that increases the QT interval in a dose-dependent fashion. Selpercatinib: (Major) Concomitant use of vardenafil and selpercatinib increases the risk of QT/QTc prolongation and torsade de pointes (TdP). Sertraline: (Moderate) Concomitant use of vardenafil and sertraline may increase the risk of QT/QTc prolongation and torsade de pointes (TdP) in some patients.